Cutler Group LP Kiniksa Pharmaceuticals, Ltd. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$10.39 - $15.15 $31,170 - $45,450	-3,000 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$13.22 - $19.09 $29,084 - $41,998	-2,200 Reduced 42.31%	3,000 $4,000
Q1 2021 Apr 26, 2021	BUY	$16.68 - $23.97 $33,360 - $47,940	2,000 Added 62.5%	5,200 $7,000
Q4 2020 Jan 21, 2021	BUY	$14.8 - $21.15 $35,520 - $50,760	2,400 Added 300.0%	3,200 $6,000
Q3 2020 Oct 27, 2020	BUY	$15.21 - $25.53 $12,168 - $20,424	800 New	800 $0

1.85M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $1.33B
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.